OREXQ Insider Trading Activity and SEC Form 4 Filings
OREXQ insider trading summary
No open-market insider purchases or sales of Orexigen Therapeutics, Inc. (OREXQ) have been reported on SEC Form 4 in the past 12 months.
Latest OREXQ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 31, 2018 | Baupost Group LLC/Ma | 10% Owner | Sell | $9K (896,339 @ $0.01) |
| Oct 31, 2018 | Baupost Group GP, L.L.C. | 10% Owner | Sell | $9K (896,339 @ $0.01) |
| Oct 31, 2018 | Seth A Klarman | 10% Owner | Sell | $9K (896,339 @ $0.01) |
| Oct 29, 2018 | Baupost Group LLC/Ma | 10% Owner | Sell | $7K (650,000 @ $0.01) |
| Oct 29, 2018 | Baupost Group GP, L.L.C. | 10% Owner | Sell | $7K (650,000 @ $0.01) |
| Oct 29, 2018 | Seth A Klarman | 10% Owner | Sell | $7K (650,000 @ $0.01) |
| Oct 25, 2018 | Seth A Klarman | 10% Owner | Sell | $7K (652,500 @ $0.01) |
| Oct 25, 2018 | Baupost Group GP, L.L.C. | 10% Owner | Sell | $7K (652,500 @ $0.01) |
| Oct 25, 2018 | Baupost Group LLC/Ma | 10% Owner | Sell | $7K (652,500 @ $0.01) |
| Oct 24, 2018 | Baupost Group LLC/Ma | 10% Owner | Sell | $280 (28,000 @ $0.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.